Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
albert Garcia Blanco
Jan 12, 2024 11:34AM ET
Avenue Therapeutics, a New York-based biotechnology company, announced on January 12, 2024 that it plans to increase its workforce by 300% by the end of April 2024. The company is hiring to work on a number of new projects , including:
A new treatment for lung cancer
Avenue Therapeutics is developing a new treatment for lung cancer that uses a combination of immunotherapy and chemotherapy. The treatment is designed to attack cancer cells more effectively and reduce the side effects of chemotherapy.
A new treatment for Alzheimer's disease
Avenue Therapeutics is developing a new treatment for Alzheimer's disease that uses a combination of drugs and gene therapy. The treatment is designed to reduce the buildup of amyloid plaques in the brain, which is believed to be one of the causes of the disease.
A new treatment for cystic fibrosis
Avenue Therapeutics is developing a new treatment for cystic fibrosis that uses a combination of gene therapy and cell therapy. Treatment is designed to correct the genetic defect that causes the disease.
These projects are unique in the world for their innovative approach to the treatment of serious diseases. If successful, they could have a significant impact on the health of patients around the world.
In addition to these projects, Avenue Therapeutics is also developing new treatments for other diseases, such as multiple sclerosis, rheumatoid arthritis and diabetes. The company is committed to researching new therapies that can improve patients' lives.
1
0
